Assessing Risks and Benefits of Invasive Cardiac Procedures in Patients with Advanced Multimorbidity

Ariela R Orkaby1, Daniel E Forman2

  • 1Division of Cardiology, VA Boston Healthcare System, 400 Veterans of Foreign Wars Pkwy, West Roxbury, MA 02132, USA; Division of Aging, Brigham & Women's Hospital, 1620 Tremont Street, Boston, MA 02120, USA.

Insights

Cardiovascular disease in older adults often co-occurs with other conditions. Risk assessments for invasive cardiac procedures need to consider patient-centered goals and multimorbidity for safer, more effective care.

Area of Science:

  • Gerontology
  • Cardiology
  • Internal Medicine

Background:

  • Age-related cardiovascular disease (CVD) in older adults frequently coexists with other chronic conditions, increasing care complexity.
  • Current risk assessment tools for invasive cardiac procedures inadequately address the unique challenges and multimorbidity profiles of geriatric populations.
  • The established benefits of invasive cardiac procedures may be less certain in older adults with multiple interacting age-related diseases.

Purpose of the Study:

  • To evaluate the limitations of current risk assessment strategies for invasive cardiac procedures in older adults with multimorbidity.
  • To propose a shift towards patient-centered goals in risk assessment for geriatric cardiovascular care.
  • To explore the potential for alternative therapies when invasive procedures present uncertain value.

Main Methods:

  • Review of existing literature on cardiovascular disease, aging, and multimorbidity.
  • Analysis of the shortcomings of standard risk stratification tools in the geriatric population.
  • Conceptual framework development for patient-centered risk assessment.

Main Results:

  • Standard risk assessment tools are insensitive to the complex interplay of age-related diseases and their impact on procedural outcomes.
  • Multimorbidity significantly complicates the decision-making process for invasive cardiac interventions.
  • A patient-centered approach can identify risks and guide the selection of appropriate therapies.

Conclusions:

  • Refocusing risk assessment on patient-centered goals is crucial for older adults with cardiovascular disease and multimorbidity.
  • Alternative therapeutic strategies may be prioritized over invasive cardiac procedures when risks outweigh benefits.
  • Improved risk assessment models are needed to optimize cardiovascular care for the aging population.

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
2.3K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
605
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
418
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
1.7K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
643
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
1.0K